1
Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted
Condition(s):Healthy SubjectsLast Updated:March 27, 2019Completed
Chlorpheniramine, Phenylpropanolamine Drug Combination: 701 Clinical Trials, Page 1 of 71
Hide Studies Not Open or Pending
2
Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
Condition(s):Healthy SubjectsLast Updated:June 17, 2019Completed
3
Mucinex® for Treatment of Filamentary Keratitis
Condition(s):Filamentary KeratitisLast Updated:February 19, 2020Completed
4
Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet
Condition(s):Healthy SubjectsLast Updated:February 28, 2019Completed
5
Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers
Condition(s):Healthy SubjectsLast Updated:February 28, 2019Completed
6
A Non-pharmacological Cough Control Therapy
Condition(s):Cough; ILD; Pulmonary Disease; Pulmonary FibrosisLast Updated:February 23, 2021Recruiting
7
Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion
Condition(s):Healthy SubjectsLast Updated:March 19, 2019Completed
8
Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Condition(s):Healthy SubjectsLast Updated:June 19, 2019Completed
9
Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate
Condition(s):Healthy SubjectsLast Updated:June 20, 2019Completed
10
Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents
Condition(s):Healthy SubjectsLast Updated:June 17, 2019Completed